eNauka - pregled

Pregled prema Autor Gastl, Guenther

Prikaz rezultata 1 do 1 od 1
GodinaNaslovAutor(i)Tip rezultataMp-kat.
2008CELSG CML 11 "ISTAHIT" Phase III Study - Planned Interim Analysis: High Doses of Imatinib Mesylate (800mg/day) Significantly Improve Rates of Major and Complete Cytogenetic Remissions (MCR, CCR) in Pretreated Ph+/BCR-ABL(+) CML Patients in Chronic PhasePetzer, Andreas L.; Wolf, Dominik; Fong, Dominic; Bošković, Darinka; Ulmer, Hanno; Gastl, GuentherKonferencijski rad
Mp kategorija će biti prikazana naknadno.